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Development and validation of a new patient-reported outcome measure for peripheral 
nerve disorders of the hand, the I-HaND© Scale  
 
 
Abstract 
Following guidelines from the Patient-Centred Outcomes Research Institute and using a 
mixed methods study, a new patient reported outcome measure for both nerve trauma and 
compression affecting the hand, the Impact of a Hand Nerve Disorders (I-HaND) Scale was 
developed.  Face-to-face interviews with 14 patients and subsequent pilot-testing with 61 
patients resulted in the development of the 32-item patient reported outcome measure.  A 
longitudinal validation study with 82 patients assessed the psychometric properties of the I-
HaND.  Content and construct validity was confirmed by cognitive interviews with patients 
and through Principal Components Analysis. The I-HaND has high internal consistency 
(α=0.98) and excellent test-retest reliability ( intraclass correlation coefficient = 0.97).  
Responsiveness statistics showed that the I-HaND is able to detect change over three 
months, discriminate between improvers and non-improvers. We conclude that the I-HaND 
can be used  as a patient reported outcome measure for people with a range of hand nerve 
disorders.   
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Introduction 
The assessment of outcome following peripheral nerve lesions remains a challenge for 
surgeons and therapists (Wang et al., 2013). Currently there is no disorder-specific patient 
reported outcome measure (PROM) suitable for patients with conditions comprising both 
traumatic and compression nerve injuries of the hand.  Two condition-specific PROMs exist 
for patients with single nerve compression type disorders: the Boston Carpal Tunnel 
Questionnaire (Levine et al., 1993) for carpal tunnel syndrome and the Patient Rated Ulnar 
Nerve Evaluation (MacDermid and Grewal, 2013) for ulnar nerve compression. However, 
neither is suitable for patients with peripheral nerve trauma.  In the absence of any 
condition specific PROM for nerve trauma,  region-specific measures designed and 
developed more generally for musculoskeletal disorders of the hand and the upper limb 
have been used instead (MacDermid, 2005; Vordemvenne et al., 2007).  They include the 
Patient Evaluation Measure (PEM) (Macey et al., 1995), the Michigan Hand Outcome 
Questionnaire (MHQ) (Chung et al., 1998; Chung et al., 1999) and the Disabilities of the Arm, 
Shoulder and Hand (DASH) (Hudak et al., 1996).   A limitation is that their content was not 
developed specifically for people with hand nerve disorders (MacDermid, 2005). 
Furthermore, these PROMs  were developed around 20 years ago and do not conform to 
current methodological standards for the development of PROMs (FDA, 2009; Patrick et al., 
2011a; Patrick et al., 2011b) namely, in-depth qualitative research methods were not used 
to develop their content.  
Developing a PROM for nerve trauma only was one option. However, a narrative review of 
qualitative studies of the impact of nerve compression (Martin, 2007; Khu et al., 2011, 
Jerosch-Herold et al., 2008) highlighted that compression syndromes also cause a significant 
burden to patients’ functioning and quality of life, thus justifying the inclusion of trauma 
and compression of nerves of the hand. The aim of this study was to develop and validate a 
new hand nerve disorder PROM, using current guidelines from the health measurement 
literature and which assesses the impact of a hand nerve disorder on body structure or 
function, activity and participation.  
 
 
 5 
Methods 
Study design and patients 
A multi-centre study using mixed methods was undertaken which comprised three phases: 
(1) item generation (qualitative methods), (2) content validation (qualitative and 
quantitative methods), and (3) psychometric evaluation (quantitative methods).   
NHS Research Ethics approval was obtained prior to commencement and all participants 
provided written and informed consent.  
 
Phase 1: Item generation  
Development of PROMs needs to have a strong conceptual basis to ensure content and 
construct validity and provide operational meaning (FDA 2009). Kathy Charmaz’s (Charmaz, 
2006) constructivist grounded theory methods were modified for this qualitative study to 
generate a theory about the impact of nerve disorders on activities and participation.  One-
to-one interviews were conducted with 14 patients with a range of hand nerve disorders. 
These data served as a basis for developing the items for the new measure (see  Ashwood et 
al., 2017 for details). Transcribed interviews were coded using the International 
Classification of Functioning, Disability and Health (ICF) (WHO, 2001) as a conceptual model.  
A hand nerve disorder-specific conceptual framework was developed and criteria for 
questionnaire design were followed to produce an item pool (Streiner and Norman, 2008). 
To ensure clinical relevance, a working group of experts was consulted during the 
development process.  This structured and methodical process was followed to establish 
face and content validity of the new measure (Mullin et al., 2000). 
 
Phase 2: Content and structural validity  
This phase comprised two stages:  Firstly, cognitive debriefing interviews as described by 
Gordon Willis (Willis, 2005) were conducted to clarify how patients understood the items 
and responses in the I-HaND version 1.  Secondly, statistical methods were used to examine 
the structural validity of the new PROM (de Vet et al., 2011).  Prospective data were 
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collected in patients with hand nerve disorders to assess how the items making up the I-
HaND scale interact (Fayers and Machin, 2013). This content validation and item refinement 
process finalised the development of the I-HaND version 2. 
 
Phase 3: Psychometric evaluation 
This phase was concerned with the evaluation of construct validity, reliability and 
responsiveness (Mokkink et al., 2010) (see Table 1 for definitions). These attributes are key 
indicators of the quality of a measure and should be considered when selecting PROMs 
(FDA, 2009). Patients with a range of nerve conditions were recruited across eight hand 
therapy centres in the UK.   At baseline, participants completed the I-HaND Scale, the Quick-
DASH and a global status measure.  These baseline data were used to evaluate construct 
validity.  To assess test-retest reliability participants were asked to complete the I-HaND a 
second time (between 7 to 14 days).  This timeframe was chosen as nerve recovery would 
not be likely, yet was long enough to minimise recall of previous responses (Frost et al., 
2007).  To assess responsiveness participants were asked to complete the I-HaND, Quick-
DASH and global status measures again at 12 weeks from baseline, during which a 
proportion of patients were likely to have experienced a change in their condition.   
 
Outcome measures 
The I-HaND version 2 comprises 32 items scored on a 5-point ordinal scale (1 to 5) giving a 
possible raw summed score range of 32 to 160 points transformed into 0-100 percentage 
score. Higher scores indicate greater disability.  There is no consensus on what proportion of 
missing items is acceptable.  De Vet et al. (2011) propose that anything greater than 15% is 
unacceptable. Using a similar threshold to the 30-item DASH, we suggest that a total score 
should not be calculated if more than 3 items have missing responses (<10%). The Quick-
DASH was used as a comparator measure at baseline and 12 weeks. A global status measure 
was used to obtain an estimation of function at baseline and 12 weeks. The percentage of 
normal hand function (%NHF) score was modified from the Stanmore Percentage of Normal 
Shoulder Assessment (SPONSA), a validated, single-item PROM (Noorani et al., 2012) 
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(supplementary file I).  A global rating of change (GROC) measure was also used at the 12-
week follow-up.  Participants were asked to rate on a three-point Likert scale whether their 
condition had improved, stayed the same or worsened. The %NHF and GROC were used as 
external anchors for the assessment of change (responsiveness) (Husted et al., 2000). A 
clinical record form asked patients questions about their sociodemographic status and 
clinicians about the patients’ peripheral nerve diagnosis and their surgical history. 
 
Statistical analysis 
Data from phases 2b and 3 were explored through descriptive analysis.  Inter-item 
correlations, range of scores, homogeneity of items, and distribution of the data and the 
presence of outliers were also explored.  The latent structure of the scale was evaluated 
using principal components analysis (PCA)1.  The internal consistency of the scale was 
examined using Cronbach’s alpha.  Construct validity was assessed by a priori hypotheses 
(Table 1). Using the Quick DASH as well as GROC and %NHF as comparators, a moderate to 
strong (Pearson’s r ≥0.6) correlation was hypothesised, as evidence of construct validity. 
Test-retest reliability was calculated using intraclass correlation coefficients (ICC).  
Responsiveness was assessed by a priori hypothesis testing (Table 1). Cohen’s effect size 
(ES) and standardised response mean (SRM) were calculated for the I-HaND and Quick-
DASH.  The GROC and % NHF were used to dichotomise patients into improvers and non-
improvers and receiver operating characteristic (ROC) curves created and the area under 
the curve (AUC) calculated.  
[Footnote :  1: The term Exploratory Factor Analysis is sometimes used to mean the same 
analysis as PCA though in general PCA and factor analysis are distinct. See deVellis (2017) 
for an interesting discussion of the terminology.]   
 
Results 
Phase 1: Concept-elicitation interviews and item generation  
Fourteen participants recruited from a single centre took part in face to face interviews. 
They were aged between 25 and 74 years with diagnoses including median or ulnar nerve 
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trauma and median, ulnar or radial nerve compression (supplementary file II).  The items for 
a 34-item I-HaND version 1 were generated from this framework (Figure 1) covering four 
domains: (1) symptoms, physical difficulties and feelings; (2) pain or discomfort; (3) 
activities and (4) participation. Careful consideration was given to the layout and 
instructions, framing of questions, response format and recall period to reduce missing or 
invalid responses and minimise cognitive and respondent burden (Streiner and Norman, 
2008).  
 
Phase 2: Content Validation  
Eleven of the 14 participants who were involved in phase 1 also took part in the cognitive 
interviews.  Examples of illustrative quotations from patients for the overall endorsement, 
content, response categories, instructions, layout and time required to complete the I-HaND 
Scale are provided in supplementary file III.  Three rounds of cognitive interviews took place, 
with revisions made to the I-HaND after each round.  The refinement to the content of the 
items for each round of interviews is presented in supplementary file III. 
Fifty participants were recruited from three UK centres for the assessment of structural 
validity.  A summary of the characteristics of the sample is provided in Table 2. Their mean I-
HaND total score was 87 points (SD = 40).  For all the items, each of the five available 
response categories was used and missing data was low (0.5%).  There were no ceiling 
effects observed. However, floor effects were observed in five items with more than 50% of 
respondents selecting the lowest category for these questions.   
 
Phase 2 - Construct (structural) validity  
A principal component analysis (PCA) was carried out on the I-HaND Scale to explore its 
structural validity.  Principal component analysis is appropriate to identify underlying 
domains (components) of instruments (Fayers and Machin, 2013).  From the 50 participants, 
42 cases were included as the analysis was based on cases with no missing values. The PCA 
of the I-HaND Scale identified four components with eigenvalues ≥ 1.00.  However, most of 
the variance (72%) was explained by the first component as can be seen in Cattell’s scree 
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plot where a sharp drop (the point of inflexion) is visible after the first component and then 
the line becomes more level (Figure 2).  The other components individually add little to the 
variability explained.    
Cronbach alpha for the I-HaND was 0.98, demonstrating excellent internal consistency. 
However, high alpha values (>0.90) can also indicate potential item redundancy (Streiner 
and Norman, 2008).  This was explored further by item-total and inter-item correlation 
analysis.  In addition to the statistical analysis the conceptual importance of items, as 
previously identified from the concept elicitation interviews, as well as their clinical 
relevance through discussion with experts on the PROM development group were used to 
determine whether items should be removed.  This approach highlighted 13 potential items 
of which three were removed (supplementary file IV) resulting in the 32-item I-HaND Scale 
version 2 (Figure 3).    
 
Phase 3: Psychometric evaluation 
Eighty-two people with a range of hand nerve disorders were recruited from eight UK 
centres.  To evaluate structural validity with a larger sample size the data from phase 2b 
were combined resulting in a sample size of 132 participants (Table 2).  Only participants 
with complete data were included in the analysis (n=118).  The mean raw total I-Hand score 
for the sample was 90 (SD=31) out of a possible 160 points.  Missing responses from 
participants were low (<1%).  There were no ceiling effects but floor effects were observed 
with three items [Q9: I feel self-conscious if people look at my hand/arm; Q12: I have hurt 
my hand and not realised it until later; and Q19: putting toothpaste on a toothbrush], with 
more than 40% of respondents selecting the lowest (easiest) category.   
Construct (structural) validity 
Of the 132 participants, 118 had complete baseline data and were included in the PCA.  
Components with Eigenvalues ≥ 1.00 were identified, following Kaiser’s criterion. The PCA of 
the I-HaND Scale revealed four components, which together explained 74% of the variance.  
Most of the variance was explained by the first component (58%). This was higher than the 
minimum recommended 50% value for a stable one-factor solution, but lower than in phase 
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2, where the first component accounted for 72% of the total variance.  The internal 
consistency of the I-HaND Scale was very high (Cronbach’s alpha 0.98).   
Hypothesis-testing construct validity  
Using the Quick DASH and %NHF as comparators baseline data were available for 82 
participants.  Seventy-two participants provided complete data. Nine participants with some 
missing data (three or less missing items) were also included in the correlation analysis by 
substituting missing items with the scale mean.  One participant who had more than 10% 
missing data was excluded.  As hypothesised, a positive, strong correlation was found 
between the I-HaND and Quick DASH (r= 0.87) and a negative, strong correlation was seen 
with %NHF (r=-0.64). 
Test-retest reliability  
Sixty-one participants completed the I-HaND Scale at baseline and 7 to 14 days (mean 12 
days, range 4 to 30 days). Complete data were available for 56 people and used in the 
analysis.    Test-retest reliability for the I-HaND was excellent (ICC = 0.97; 95% CI = 0.94 to 
0.98).   
 
Responsiveness to change 
Fifty participants completed the I-HaND at baseline and at the second follow-up (12 weeks) 
providing data for the responsiveness analysis.  Forty-five participants provided complete 
data; five participants who had < 10% missing data (three or less missing items) were also 
included in the analysis, by substituting missing items with the scale mean.  One participant 
who had more than 10% missing data was excluded.  Effect sizes (ES) and standardised 
response means (SRM) for the I-HaND were moderate (ES=0.51; SRM=0.60) and marginally 
higher than the Quick DASH (Table 1). 
The  hypothesis that the I-HaND can discriminate between patients who reported 
themselves as improved and those remaining the same or worse was evaluated by 
constructing ROC curves and calculating the area under the curve. The larger the area under 
the curve (closer to 1), the greater the ability of the scale to discriminate (Husted et al, 
2000).  The group was dichotomised into improvers and non-improvers using the global 
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change (GROC) measure.  The global status measure (%NHF) scores at baseline and follow-
up were also converted into a change score to create an additional patient anchor with 
which to classify patients into improvers and non-improvers.  The area under the curve was 
large (≥0.82) for both types of anchors  (Table 1, Figures 4a and b).  
 
 
Discussion 
An in-depth qualitative study of the impact of hand nerve disorders including trauma and 
compression generated a conceptual framework from which a new PROM for hand nerve 
disorders was developed, the I-HaND. Cognitive interviews confirmed that patients found 
the I-HaND relevant, highly acceptable and quick to complete. Subsequent psychometric 
evaluation of the 32-item I-HaND confirmed its construct validity, high internal consistency,  
excellent test-retest reliability and that it is responsive over three months.  
Our study took an approach to scale refinement that is recommended (FDA, 2009) but 
differs from the approaches adopted by others in the field of hand surgery and 
rehabilitation.  Specifically, the I-HaND Scale was developed on the basis of patient 
interviews, which defined the areas for scale content (Patrick et al., 2011a; Patrick et al., 
2011b).  In hand surgery and rehabilitation it has been typical to develop an item pool based 
on expert clinicians’ opinion or from the literature, followed by an item-reduction process 
using factor analysis (Chung et al., 1998; Hudak et al., 1996).  With this approach, the 
content of a scale, rather than the construct intended for measurement, defines what the 
scale measures (Hobart et al., 2007).  
Cognitive debriefing interviews with patients provided further evidence that previous steps 
taken to ensure trustworthiness had been effective and that the preliminary I-HaND was 
clear, understood and relevant for people with nerve conditions.   The complementary use 
of statistical methods, identified strengths and weaknesses of the developing PROM.  Only 
minor changes were made, as caution is advocated when making changes to newly 
developed instruments on the basis of small samples and therefore a very parsimonious 
approach to item reduction was taken to retain content and clinical validity.   
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Classical test theory methods were used to assess the psychometric properties of the I-
HaND and our results provide initial evidence of this. The proportion of missing data was 
low, suggesting that it was acceptable to patients.  Scale scores spanned the entire range of 
response options. There were some floor effects, however, PROMs need to be able to 
capture different levels of ability so the fact that some items were easy for some people but 
not for others was desirable.  The exploratory PCA supports the notion of a unidimensional 
scale with high internal consistency, as demonstrated with a high alpha coefficient and item-
total correlations. An alpha of 0.90 to 0.95 is desirable (Bland and Altman, 1997), although 
our α = 0.98 exceeds this and may indicate some item redundancy.  The high number of 
items making up the I-HaND scale may also inflate alpha. However, moderate to strong 
item-total correlations, provided further evidence that the items are measuring different 
aspects of the same construct and there were no correlations >0.9.  Whilst there is a trend 
towards producing shorter versions of PROMs, this can be at the expense of patient and 
clinical relevance.  The PCA identified that one factor explained over 58% of the score 
variance although this was substantially lower than in phase 2. This discrepancy may be due 
to smaller sample sizes used in phase 2.  In phase 3, sample sizes were on the borders of 
acceptability for the assessment of structural validity (Mokkink et al., 2010).  Although some 
authors argue that useful estimates can be obtained from small samples, further 
examination of the structure of the I-HaND in larger samples is needed  (Hobart et al., 
2012). 
Test-retest reliability was excellent.  The generated hypotheses relating to the strength of 
association with the Quick-DASH and %NHF were supported, thus providing evidence of 
construct validity. Although the correlation is stronger than hypothesised it does not 
indicate that these instruments measure the same constructs. The Quick-DASH is made up 
of 11 items compared to 32 in the I-HaND. Furthermore patients gave strong endorsement 
to the relevance of items in the I-HaND such as ‘You would think that it was made for me to 
be honest’ and ‘Everything in there was what actually occurred and what I have been 
through’. Finally, the time required to complete the I-HaND is relatively short, with 
participants taking between three and seven minutes, which would be considered a minimal 
burden.   
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The use of classical test theory methods for the development of new PROMs has been 
criticised (Cano and Hobart, 2011) as these methods produce measures which are ordinal in 
nature, in that they describe order but not the relative size or degree of the difference 
between measurements.  A more modern approach to scale development is the use of 
Rasch measurement methods which have the ability to construct linear, interval-level 
measurements from ordinal-level rating scale data (Cano et al., 2011). Further exploration 
of the structural validity of the I-HaND using Rasch model analysis is recommended.   
The results of this study provide evidence that the I-HaND Scale can measure change over 
time, when change is expected.  This is particularly important for condition-specific PROMs 
(Guyatt et al., 1987).  The use of distribution and anchor-based methods to assess external 
responsiveness provided a more meaningful estimate of change, as patients have defined 
this themselves (Wyrwich et al., 2013).  In addition using two patient measures - global 
status and global change, can help to minimise the effect of recall bias associated with 
global rating of change (Norman et al., 1997).  
A limitation of the responsiveness study is that whilst the overall sample size was good, 
when the group was dichotomised into groups of improvers and non-improvers, each sub-
group was small.  In responsiveness studies, change is usually reported in relation to a 
known effective intervention, such as carpal tunnel decompression.  In this study patients 
with a range of different nerve diagnoses were recruited, undergoing a wide range of 
conservative and surgical treatments and over a relatively short time span.  This may explain 
why the effect size for the I-HaND was only modest compared to the Quick-DASH.  On the 
other hand, a potential benefit of this approach is that the people recruited were 
representative of the target population.  Further work is necessary to evaluate the 
responsiveness of the I-HaND Scale over a longer period and define minimally clinically 
important difference (MCID) which is an aspect of a PROM’s interpretability (Mokkink et al., 
2010).  
Subject to further psychometric testing, including Rasch model analysis, the I-HaND Scale 
has the potential to be used in research as part of an agreed core outcome set for nerve 
disorders of the hand and in future clinical trials (Williamson et al., 2012).  The I-Hand 
version 2 is a clinically useful instrument which patients find relevant, quick and easy to 
complete. It can be used for the routine evaluation of outcome for peripheral nerve 
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disorders of the hand, outcomes that are ultimately best judged by patients themselves and 
can support patient-focused decision making and goal planning. The I-HaND could be used 
as a complementary outcome measure to other clinician-derived impairment scores such as 
the validated Model Instrument for the Documentation of Outcome after Nerve Repair, also 
known as the Rosén score (Rosén and Lundborg, 2000).  
 
Acknowledgement: Hard copies of the I-HaND version 2 can be obtained under a creative 
commons license from the corresponding author. (https://www.uea.ac.uk/health-
sciences/research/research-groups/rehabilitation/musculoskeletalrehabilitation/resources-
and-tools).  
 
Figures and Tables 
Figure 1. Conceptual framework derived from patient interviews of impact of hand nerve 
disorders using the WHO ICF. 
Figure 2. Cattel’s scree plot of Eigenvalues for the components of the I-HaND Scale and 
point of inflection (arrow). 
Figure 3. Questions and response categories for the Impact of Hand Nerve Disorders (I-
HaND) Scale.   
Figure 4. Receiver operating characteristic (ROC) curve showing area under the curve for I-
HaND score change compared with (a) global rating of change (GROC) and (b) percentage of 
normal hand function (%NHF) change. 
 
Table 1. Overview of psychometric properties assessed for the I-HaND including definitions, 
methods used and summary of results. 
Table 2. A summary of the sociodemographic and clinical characteristics of participants at 
baseline and follow-up. 
 
Supplementary Files (online only) 
Supplementary file I: Percentage of Normal Hand Function 
Supplementary file II: Characteristics of study sample from Phase 1 study (interviews) 
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Supplementary file III: Examples of illustrative quotations from patients for the overall 
endorsement, content, response categories, instructions, layout and time required to 
complete the I-HaND Scale 
Supplementary file IV: Development of the content of the items of the I-HaND Scale with 
changes made highlighted in bold 
Supplementary file V: Summary of item-revision process (Phase 2), with changes highlighted 
in bold 
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Table 1: Overview of psychometric properties assessed for the I-HaND including definitions, methods used and summary of results 
Domain Measurement 
property 
Definition (from COSMIN) Methods Results for I-HaND 
Validity Content 
validity  
The degree to which the items of the 
PRO – instrument look like an adequate 
reflection of the construct to be 
measured  
Phase 1 – qualitative study involving 
interviews with 14 patients from the target 
population  
                                                                               
Phase 2a – qualitative study involving 
cognitive interviews with 11 patients from 
the target population 
 
Development of a conceptual framework 
on the impact of a hand nerve disorder 
from which items for the I-HaND were 
generated 
Patients confirmed I-HaND scale as 
relevant and acceptable (see 
supplementary file I) 
 Face validity The degree to which the items of a PRO 
instrument indeed look as though they 
are an adequate reflection of the 
construct to be measured  
Phase 1 - review by a PROM development 
group with experience in upper limb 
rehabilitation, outcome measurement and 
PROM development 
 
Face validity established by PROM 
development group  
Construct 
validity 
Structural 
validity 
The degree to which the scores of a 
PRO instrument are an adequate 
reflection of the dimensionality of the 
construct being measured 
Phase 2b & 3 – dimensionality explored 
using Principal Component Analysis (PCA) of 
I-HaND scores 
58% of variance explained by 1st 
component (PC1),  item loading >0.5 on 
PC1 for all items, communalities  range 
from 0.5 to 0.7 
 Hypothesis-
testing 
The degree to which scores on the PRO 
instrument are consistent with 
hypotheses regarding its relations hip 
to scores on other instruments 
a priori hypotheses:  
I-HaND scores will show a positive, 
moderately strong correlation (>0.6) with 
the Quick-DASH and negative, moderately 
strong correlation (> -0.6) with the %NHF 
 
Correlation with Quick-DASH r=0.87 
Correlation with % NHF  r= -0.64 
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Reliability  Test-retest Extent to which scores for patients who 
have not changed are the same over 
time 
Phase 3 study – repeated administration of          
I-HaND over 7 to 14 day interval, in a stable 
group where no change was anticipated.  
Quantified using Intra-class correlation 
coefficient (ICC) 
ICC = 0.97     95%CI = 0.94 to 0.98 
 Internal 
consistency 
The degree of the interrelatedness of 
the items 
Phase 2b & 3 – statistical examination of the 
interrelatedness of items using Cronbach’s 
alpha 
Cronbach alpha = 0.98 
Responsiveness  Responsiveness The ability of a PRO instrument to 
detect change over time in the 
construct being measured 
a priori hypotheses:  
1)the I-HaND can detect change over a 12 
week period measured by effect size of  
>0.5, in a group where change is expected  
2) the I-HaND can discriminate between 
Improvers and non-improvers  
3) the I-HaND will be more responsive 
relative to the Quick DASH 
 
I-HaND  ES=0.51, SRM=0.60  
 
AUC using GROC = 0.82 (95%CI 0.70;0.94)              
AUC using %NHF = 0.83 (95%CI 0.71;0.94)    
Quick-DASH ES=0.42, SRM=0.56               
AUC = area under the curve, ES = effect size GROC = global rating of outcome,  CI= confidence interval, NHF= percentage of normal hand function, PRO = patient rated 
outcome, PC = principal component, SRM = standardised response mean 
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Table 2: A summary of the sociodemographic and clinical characteristics of participants at 
baseline and follow-up 
 Phase 2b Phase 3 
 Structural 
Validity 
(N=50) 
Structural 
validity 
(N = 132) 
 Hypothesis 
testing 
(N = 82) 
Test-retest 
reliability 
(N = 61) 
Responsive-
ness 
(N = 50) 
No. (%) of men 27 (54%) 72 (55%)  49 (60%) 39 (64%) 29 (58%) 
Mean age (range) in years 55 (18 to 88) 52 (18 to 93)  49 (18 to 75) 52 (21 to 
93) 
54 (21 to 93) 
Carpal tunnel syndrome 20 (40%) 42 (32%)  22 (27%) 18 (30%) 14 (28%) 
Cubital tunnel syndrome 1 (2%) 12 (9%)  11 (13%) 8 (13%) 9 (18%) 
Radial nerve palsy 9 (18%) 16 (12%)  7 (9%) 4 (7%) 4 (8%) 
Median nerve injury 7 (14%) 23 (17%)  16 (20%) 12 (20%) 9 (18%) 
Ulnar nerve injury 7 (14%) 19 (14%)  12 (14%) 11 (18%) 8 (16%) 
Combined nerve lesion  3 (6%) 17 (13%)  14 (17%) 8 (13%) 6 (12%) 
Concomitant injury  21 (42%) 54 (41%)  33 (40%) 22 (36%) 16 (32%) 
Treated surgically  42 (84%) 109 (83%)  67 (82%) 52 (85%) 43 (86%) 
Mean duration (range) in 
months: 
39 (2 to 367) 29 (1 to 367)  22 (1 to 179) 24 (1 to 79) 27 ( 1 to 79) 
Mean time since surgery 
(range) in months 
15 (1 to 88) 9  (1 to 88)  5 (1 to 24) 5 (1 to 20) 5 (1 to 19) 
Dominant hand affected  22 (44%) 55 (42%)  33 (40%) 23 (38%) 19 (38%) 
Living alone 8 (16%) 17 (13%)  9 (11%) 7 (12%) 6 (12%) 
Caring for others 17 (34%) 36 (27%)  19 (23%) 16 (26%) 14 (28%) 
Working  24 (48%) 68 (52%)  44 (54%) 31 (51%) 28 (56%) 
Changed work 13 (26%) 36 (27%)  23 (28%) 16 (26%) 11 (22%) 
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Figure 1 
 
 
  
Peripheral Nerve Disorder 
Activities (limitations) 
 
 Doing up buttons, dressing, cutting 
nails, washing body, putting on 
deodorant, squeezing toothpaste 
 Using a knife and fork, opening lids, 
lifting kettle or teapot, chopping 
food, lifting heavy pots and pans 
 Carrying heavy shopping, wringing 
out a cloth, hanging out washing 
 Opening/closing doors, lifting heavy 
items 
 Dexterity – finding keys in pocket, 
hand writing, dropping things turning 
pages of book 
Body structures/function 
(impairments) 
 
 Movement, strength, dexterity and 
endurance  
 Pain, sleep, cold intolerance, 
allodynia 
 Pins and needles, numbness, loss 
of protective sensation 
 Body image, emotional response, 
fear avoidance, self-efficacy 
Environmental factors 
 Assistive devices 
 Disease process, healing, therapy 
 Communication from the medical team 
 Social support 
 Time  
 
Personal factors  
 Personality 
 Motivation 
 Acceptance 
 Adaptation 
 Perception of functional capacity, handedness 
Participation (restrictions) 
 
 Physical demands of work 
 Difficulty managing pace of 
work 
 
 Social life – shaking hands 
 
 Difficulty performing 
recreational tasks 
 Impact on confidence with 
recreational tasks 
 Fear and avoidance of 
recreational tasks 
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Figure 2: Cattel’s scree plot of Eigenvalues for the components of the I-HaND Scale and point of 
inflection (arrow) 
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Figure 3: Questions and response categories for the Impact of Hand Nerve Disorders (I-HaND) Scale   
 
Part 1: questions ask about any symptoms, physical difficulties and feelings experienced as a result of your nerve disorder of the 
hand(s) over the past week.   
1. How well did your hand(s) work? Very well (1) to very 
poorly (5) 
How satisfied are you with the following? 
2. The movement of your hand(s)  
Very satisfied (1) to very 
dissatisfied (5) 
3. The sense of touch in your hand(s)  
4. The strength in your hand(s) 
Please indicate how often you have experienced the following in the past week 
5. I can’t grip or pinch for very long without my hand getting tired  
Never (1) to always (5) 6. When I touch certain things it causes pins and needles or tingling 
7. When I go to pick something up it falls out of my hand 
Please indicate how often you have experienced the following in the past week 
8. Using my hand(s) can bring about strong emotions e.g. frustration, anger, sadness  
Never (1) to always (5) 9. I feel self-conscious if people look at my hand/arm 
 
Part 2: The following questions ask about any pain or discomfort that you may have experienced as a result of your nerve disorder 
of the hand(s).   
10. The pain or discomfort in my hand(s) has been  None (1) to very severe (5) 
11. How often would you say that your pain or discomfort impacts on your daily 
routine? 
 
 
Never (1) to always (5) 12. I have hurt my hand and not realised it until later 
13. My hand feels over sensitive when touched 
14. I feel pain or discomfort  when my hand is cold 
15. It is difficult to get a good night’s sleep because of the pain or discomfort in my 
hand/arm 
 
Part 3: The following questions ask about difficulty with activities that you may have experienced as a result of your nerve disorder 
of the hand(s).   
16. How well have you been able to carry out your daily routine e.g. getting ready, 
cooking, childcare etc. 
Very well (1) to very 
poorly (5) 
How difficult has it been for you to complete the following activities? 
17. Getting dressed or undressed  
 
 
 
 
Not at all difficult (1) to 
unable (5) 
18. Doing up buttons 
19. Putting toothpaste on a toothbrush 
20. Cutting your nails 
21. Cutting food using a knife & fork together 
22. Opening lids of tight jars and bottles 
23. Pouring from a kettle 
24. Wringing out a cloth 
25. Preparing a meal  
26. Opening & closing heavy doors 
27. Turning pages of a book, magazine or newspaper 
28. Using electronic devices e.g. a remote control, mobile phone, tablet or computer 
29. Carrying a heavy shopping bag 
30. Handling small coins e.g. 5 pence or 1 pence 
Part 4: The following questions ask about how your nerve disorder of the hand(s) has affected your ability to take part in your 
daily work (including paid work, school work or housework) and recreational activities.     
31. How well have you been able to manage the physical demands of your daily work? Very well (1) to very 
poorly (5) 32. How well have you been able to take part in recreational activities e.g. Hobbies or 
sport?  
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Figure 4a: Receiver operating characteristic (ROC) curve of I-HaND using GROC 
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Figure 4b: Receiver operating characteristic (ROC) curve of I-HaND using %NHF  
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Supplementary file I 
Percentage of Normal Hand Function 
 
 
Please read the following statement: 
“A normal hand is one which is pain-free, with a full range of movement, normal strength, dexterity and 
sensation, and allows you to do what you feel your hand, if normal, should allow you to do. A normal hand is 
scored as 100 percent, while a completely useless hand is scored as 0 percent. Overall where would you 
rate your hand between 0 and 100 percent, at this present time” 
 
  
% Percentage of Normal Hand Function 
Participant Identification Number:           Baseline / Follow-up 1 / Follow-up 2                                                                
PLEASE PROVIDE THE DATE THAT YOU COMPLETED THIS FORM HERE:  / /  
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Supplementary file II: 
 
Characteristics of study sample from Phase 1 study (interviews) 
Diagnosis  age sex Duration 
(months) 
Work status Intervention  
 Median Nerve  Injury 59 M 34 Light manual 10 repair 
 63 F 28 Volunteer 10 repair 
 26 M 35 Skilled manual 10 repair 
      
Ulnar nerve injury 74 M 47 Skilled manual 10 repair 
 25 M 25 Heavy manual 10 repair 
 66 M 7 retired 10 repair 
 26 F 24 retail graft 
 62 F 72 Skilled manual decompression 
      
Ulnar nerve compression 
(UNC)  
59 M 58 retired transposition 
      
Combined UNC and CTS 71 F 60 retired Transp/decomp 
      
Carpal tunnel syndrome 
(CTS) 
71 F 108 carer decompression 
 56 F 39 retail decompression 
      
Radial nerve palsy 57 M 44 managerial conservative 
 61 F 52 Office work decompression 
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Supplementary file III:  
Examples of illustrative quotations from patients for the overall endorsement, content, response categories, 
instructions, layout and time required to complete the I-HaND Scale 
Patient endorsement 
categories  
Examples of illustrative quotations from patients  
 
Overall endorsement “It’s simple to use, it’s simple to understand, I don’t really 
think it needs changing”. 
 “It’s nicely set out, it’s easy to read, it’s easy to mark and it 
covers everything that should have been asked”. 
 “I didn’t have any trouble answering the questions”. 
 “I didn’t have to think twice about any of the questions”. 
 “I think it is more simple and straight forward than the 
majority of questionnaires you get at the hospital”. 
 “You would think that it was made for me to be honest”. 
 “Everything in there was what actually occurred and what I 
have been through”. 
Content “One question I like in particular was the question about 
emotions”. 
 “Nobody asks about that and you do feel these emotions 
because you have lost part of you, lost part of the use of 
you, so you get very frustrated”. 
 “It seems to cover everything that affects me”. 
 “As I said it is more or less designed for me that one”. 
 “It covers everything that should be asked or should have 
been asked”. 
 “It’s very impressive, I like the way it is all everyday tasks 
that are being asked about”. 
Response categories “I thought it was really good, especially the range of 
answers.  You’ve got five choices as opposed to three and 
you can really pin it down”. 
 “I think it is well thought out; the range of answers”. 
Instructions “The instructions are self-explanatory”. 
 “It was pretty easy to follow, it was good”. 
Layout “The layout is lovely, it is fine, I can’t pick any holes in it 
really”. 
 “The print is a decent size which makes a change for us old 
people”. 
 “I like how you have greyed out every other line to make it 
easier to follow across”. 
Time frame “It isn’t that long; I’ve had a lot longer ones to complete”. 
 “It’s quite short really”. 
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Supplementary file IV:  
Development of the content of the items of the I-HaND Scale with changes made highlighted in bold  
Item at pre-test Round 1 Round 2 Round 3 
How well did your hand(s) work? No change No change Retained 
The movement of your hand(s) No change  No change Retained 
The sense of touch in your hand(s)  No change No change Retained 
The strength in your hand(s) No change  No change Retained 
I can’t grip or pinch for very long without my hand 
getting tired 
No change No change Retained 
When I touch certain things it causes pins and needles 
or tingling 
No change No change Retained 
I have hurt my hand and not realised it until later No change No change Retained 
When I go to grab something it just falls out of my hand Revised No change Retained 
Using my hand(s) can bring about strong emotions e.g. 
frustration, anger, sadness 
No change No change Retained 
I feel self-conscious if people look at my hand/arm No change No change Retained 
The pain in my hand(s) has been (…) No change No change Retained 
How often would you say that your pain impacts on 
your daily routine? 
No change No change Retained 
I am sensitive in my hand and do not like it to be 
touched 
Revised No change Retained 
I feel discomfort or pain in cold weather or  when 
handling cold objects 
Revised No change Retained 
It is difficult to get a good night’s sleep because of the 
pain in my hand/arm 
No change Revised Retained 
How well have you been able to carry out your daily 
routine, e.g. getting ready, cooking, childcare etc. 
No change No change Retained 
Doing up buttons No change No change Retained 
Cutting food using a knife & fork together No change No change Retained 
Cutting your nails No change No change Retained 
Washing your body No change No change Retained 
Putting toothpaste on a toothbrush No change No change Retained 
Getting dressed or undressed No change No change Retained 
Opening lids of tight jars and bottles No change No change Retained 
Pouring from a kettle No change No change Retained 
Carrying a heavy shopping bag No change No change Retained 
Wringing out a cloth No change No change Retained 
Preparing a meal  No change No change Retained 
Opening & closing heavy doors No change No change Retained 
Handwriting No change No change Retained 
Turning pages of a book, magazine or newspaper No change No change Retained 
Handling small coins e.g. 5 pence or 1 pence No change No change Retained 
Using electronic devices e.g. a remote control, mobile 
phone, tablet or computer 
No change No change Retained 
How well have you been able to manage the physical 
demands of your daily work? 
No change No change Retained 
How well have you been able to take part in recreational 
tasks, e.g. hobbies or sport?  
Revised No change Retained 
Driving a car   Added  
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Supplementary file V: Summary of item-revision process (Phase 2), with changes highlighted in 
bold 
Items with poor fit   Reason for selection  Decision 
Q1: How well did your hand(s) 
work?  
≥ 0.9 item-total correlation Retained 
≥ 0.9 inter-item correlation 
Q2: The movement of your hand(s) ≥ 0.9 inter-item correlation Retained 
Q12: I have hurt my hand and not 
realised it until later 
≥ 50% no. 1 responses  
(floor effect) 
Retained  
Q16: How well have you been able 
to carry out your daily routine e.g. 
Getting ready, cooking, childcare 
etc. 
≥ 0.9 item-total correlation Retained 
Q17: Washing your body ≥ 50% no. 1 responses  
(floor effect) 
Removed  
≥ 0.9 inter-item correlation 
Q20: Putting toothpaste on a 
toothbrush 
≥ 50% no. 1 responses  
(floor effect) 
Retained 
Q24: Pouring from a kettle ≥ 50% no. 1 responses  
(floor effect) 
Retained 
Q33: Driving a car ≥ 50% no. 1 responses  
(floor effect) 
Removed 
≥ 5% missing item 
Written comments from participants  
Q28: Handwriting  Written comments from participants Removed 
Q18: Getting dressed or undressed
  
≥ 50% no. 1 responses  
(floor effect) 
Retained 
≥ 0.9 inter-item correlation  
 
Q26: Preparing a meal ≥ 0.9 inter-item correlation Retained 
≥ 0.9 item-total correlation 
Q25: Wringing out a cloth ≥ 0.9 inter-item correlation Retained 
≥ 0.9 item-total correlation 
Q27: Opening & closing heavy 
doors 
≥ 0.9 inter-item correlation Retained 
 
 
 
